To further investigate whether the 125I seed in CCA plays a role in cancer suppression by upregulating ROS generation and promoting p53 expression, we first treated RBE and HCCC-9810 cells with 0.4 and 0.8 mCi doses of 125I seed for 72 h, respectively. Here, TP53 is linked to cholangiocarcinoma.